Randox Toxicology was established in 2012 as a result of Randox’ success and growth in the toxicology market. Headquarters is in the UK with offices and distributors in over 129 countries including the Philippines.
Randox Toxicology adheres to diagnostic accredited manufacturing standards aiding forensic toxicology laboratories achieve ISO 17025 and adhere to best practice accreditation principles.
And has the largest toxicology test menu on the market spanning over 500 drugs and drug metabolites.
Randox manufacture State of the art multiplex immunoassays analyzer using the Biochip Array Technology – the most advanced forensic drug screening technology on the market.
FEATURES AND BENEFITS
Simultaneous Analyte Detection
The multiplex testing capabilities of Biochip Array Technology facilitates simultaneous screening of various drug metabolites across six toxicology arrays on the Evidence Investigator.
Extensive Test Menu
With more novel and routine drugs tests available than any other sole supplier, the Evidence Investigator utilises the world's largest toxicology test menu.
Small Sample Volume
When using the Evidence Investigator, only a small sample volume of 7-25 µl is required, leaving more sample remaining for confirmatory testing.
The Evidence Investigator facilitates highly sensitive immunoassay screening of multiple matrices including serum, plasma, whole blood, oral fluid, urine and forensic matrices.
Multiplex analysis minimses analytical variation between tests and has a proven high standard of accurate tests results with CVs typically <10% with a reduction in false positives.
Multi-analyte controls and calibrators and multiplex testing capabilities facilitate laboratory efficiency and deliver a cost consolidating solution for the toxicology laboratory.